AU2003241149A1 - Amorphous clopidogrel hydrogen sulfate composition - Google Patents

Amorphous clopidogrel hydrogen sulfate composition

Info

Publication number
AU2003241149A1
AU2003241149A1 AU2003241149A AU2003241149A AU2003241149A1 AU 2003241149 A1 AU2003241149 A1 AU 2003241149A1 AU 2003241149 A AU2003241149 A AU 2003241149A AU 2003241149 A AU2003241149 A AU 2003241149A AU 2003241149 A1 AU2003241149 A1 AU 2003241149A1
Authority
AU
Australia
Prior art keywords
hydrogen sulfate
clopidogrel hydrogen
sulfate composition
amorphous clopidogrel
amorphous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003241149A
Inventor
Male Srinivas Reddy
Pothireddy Venkateswar Reddy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hetero Drugs Ltd
Original Assignee
Hetero Drugs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hetero Drugs Ltd filed Critical Hetero Drugs Ltd
Publication of AU2003241149A1 publication Critical patent/AU2003241149A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003241149A 2003-05-05 2003-05-05 Amorphous clopidogrel hydrogen sulfate composition Abandoned AU2003241149A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2003/000175 WO2004098593A1 (en) 2003-05-05 2003-05-05 Amorphous clopidogrel hydrogen sulfate composition

Publications (1)

Publication Number Publication Date
AU2003241149A1 true AU2003241149A1 (en) 2004-11-26

Family

ID=33428275

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003241149A Abandoned AU2003241149A1 (en) 2003-05-05 2003-05-05 Amorphous clopidogrel hydrogen sulfate composition

Country Status (2)

Country Link
AU (1) AU2003241149A1 (en)
WO (1) WO2004098593A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006074066A1 (en) * 2004-12-30 2006-07-13 Nektar Therapeutics Non-crystalline formulation comprising clopidogrel
EP2001449A2 (en) * 2006-04-05 2008-12-17 Cadila Healthcare Ltd. Modified release clopidogrel formulation
PT1847258E (en) 2006-04-13 2010-06-22 Riemser Specialty Production G Partial glycerides as lubricants in pharmaceutical compositions comprising thieno[3,2-c]pyridine derivatives
EP1970054A3 (en) 2007-03-14 2009-06-03 Ranbaxy Laboratories Limited Clopidogrel tablets
BRPI0810168A2 (en) * 2007-04-09 2014-12-30 Usv Ltd PHARMACEUTICAL COMPOSITIONS OF CLOPIDOGREL BISULPHATE AND PREPARATION PROCESSES
WO2008129468A2 (en) * 2007-04-20 2008-10-30 Wockhardt Research Centre Pharmaceutical compositions of clopidogrel
EP2107061A1 (en) 2008-04-02 2009-10-07 Krka Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of optically enriched clopidogrel
CN101766573B (en) 2010-02-05 2013-02-13 上海安必生制药技术有限公司 Preparation process of clopidogrel bisulfate solid preparation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2664276B1 (en) * 1990-07-04 1992-10-23 Sanofi Sa GLYCIDIC THIENYL-2 DERIVATIVE, ITS PREPARATION METHOD AND ITS USE AS A SYNTHESIS INTERMEDIATE.
US5576328A (en) * 1994-01-31 1996-11-19 Elf Sanofi Method for the secondary prevention of ischemic events
FR2769313B1 (en) * 1997-10-06 2000-04-21 Sanofi Sa DERIVATIVES OF HYDROXYACETIC ESTERS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS SYNTHESIS INTERMEDIATES

Also Published As

Publication number Publication date
WO2004098593A1 (en) 2004-11-18

Similar Documents

Publication Publication Date Title
AU2003287682A1 (en) Amorphous alloy stents
IL175702A0 (en) Nanoscale crystalline silicon-powder
AU2003903839A0 (en) Battery characterisation
GB0329449D0 (en) Stem cells
PL1612200T3 (en) Fertilising composition
IL178511A0 (en) Stable amorphous cefdinir
EP1548143A4 (en) Cu-BASE AMORPHOUS ALLOY
EP1457822A3 (en) Positive resist composition
AU2003269140A1 (en) Clopidogrel
AU2003282500A1 (en) Anti-corrosion composition
AU2003241149A1 (en) Amorphous clopidogrel hydrogen sulfate composition
AU2003216707A1 (en) Amorphous clopidogrel hydrogen sulfate
GB0302929D0 (en) Nutrient composition
AU2003263585A1 (en) Amorphous duloxetine hydrochloride
AU2003902430A0 (en) Masterbatch composition
GB0314149D0 (en) Novel amorphous forms
AU2003252320A1 (en) Acid-resistant mortar composition
AU2003100144A4 (en) Lousicide composition
GB0407620D0 (en) Cell lines
AUPS088302A0 (en) Metering tap
AU2003269233A1 (en) Soap composition
GB2417421B (en) Tooth-whitening composition
AU2005100106A4 (en) T&L ezyfume
AU2003295616A1 (en) Spatial for altering cell proliferation
GB0327906D0 (en) Biocatalyst composition

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase